Related Experiment Video

Updated: May 25, 2026

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells
08:02

In Vivo Immunogenicity Screening of Tumor-Derived Extracellular Vesicles by Flow Cytometry of Splenic T Cells

Published on: September 23, 2021

Cell-derived microvesicles and antitumoral multidrug resistance

Irène Tatischeff1

  • 1Laboratoire acides nucléiques et biophotonique (ANBioPhi), UPMC/CNRS, 4, place Jussieu, case courrier 138, 75252 Paris cedex O5, France. irene.tatischeff@upmc.fr

Comptes Rendus Biologies
|February 14, 2012
PubMed

Insights

Multidrug resistance (MDR) in cancer may stem from tumor cells expelling chemotherapy drugs via microvesicles. This study proposes cell-derived vesicles as a novel mechanism for drug resistance and suggests experiments to validate this hypothesis.

Area of Science:

  • Oncology
  • Cell Biology
  • Biochemistry

Background:

  • Multidrug resistance (MDR) complicates cancer chemotherapy.
  • Understanding MDR mechanisms is crucial for improving treatment efficacy.
  • Previous research highlights the complexity of tumor resistance to antineoplastic drugs.

Purpose of the Study:

  • To propose a novel hypothesis for multidrug resistance (MDR) in tumor cells.
  • To investigate the role of cell-derived microvesicles in mediating MDR.
  • To suggest experimental approaches for validating the proposed mechanism.

Main Methods:

  • Observations from the non-pathogenic microorganism Dictyostelium discoideum.
  • Analysis of recently published observations in tumoral human cells.
  • Hypothesizing the function of cell-derived vesicles in drug transport and resistance.

Main Results:

  • Cell-derived vesicles may prevent chemotherapeutic agents from reaching intracellular targets.
  • These vesicles might facilitate the expulsion of antineoplastic drugs from tumor cells.
  • Cell-derived vesicles could function as intercellular transporters of multidrug resistance proteins.

Conclusions:

  • Cell-derived microvesicles represent a potential detoxification mechanism in tumor cells.
  • This mechanism could explain how tumor cells acquire or exhibit multidrug resistance.
  • Further experiments are needed to confirm the role of microvesicles in mediating MDR.

More Related Videos

Isolation and Characterization of Microvesicles from Peripheral Blood06:03

Isolation and Characterization of Microvesicles from Peripheral Blood

Published on: January 6, 2017

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics08:50

Scalable Biomanufacturing Workflow to Produce and Isolate Natural Killer Cell-Derived Extracellular Vesicle-Based Cancer Biotherapeutics

Published on: August 16, 2024

Related Concept Videos

Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Mesenchymal Stem Cells01:19

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...